Fig. 2From: The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a reviewSynthetic lethality demonstrated between BRCA1/2 and PARP. Defects in either BRCA1/2 or PARP does not lead to cell death; however simultaneous defects or inhibition of both proteins leads to cell deathBack to article page